Predicate Research Report · generated 2026-08-21 · Print / save as PDF · Save to account
Ark Diagnostics, Inc. — Predicate Candidate Screening
17 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.
166 daysmedian FDA review time
294 days90th percentile
17clearances measured
| K-number | Device | Applicant | Decided | Review days | Recalls (K-match) |
|---|---|---|---|---|---|
| K232522 | ARK Levetiracetam II Assay | Ark Diagnostics, Inc. | 2024-02-27 | 193 | 0 |
| K232017 | ARK Methotrexate II Assay | Ark Diagnostics, Inc. | 2023-12-20 | 166 | 0 |
| K231752 | ARK Hydrocodone Assay | Ark Diagnostics, Inc. | 2023-11-09 | 147 | 0 |
| K201089 | ARK Lacosamide Assay | Ark Diagnostics, Inc. | 2021-08-05 | 469 | 0 |
| K200197 | ARK Fentanyl II Assay | Ark Diagnostics, Inc. | 2020-02-26 | 30 | 0 |
| K182280 | ARK Tramadol Assay | Ark Diagnostics, Inc. | 2018-12-10 | 110 | 0 |
| K182779 | ARK EDDP Assay | Ark Diagnostics, Inc. | 2018-11-21 | 51 | 0 |
| K180427 | ARK Fentanyl Assay | Ark Diagnostics, Inc. | 2018-06-06 | 110 | 0 |
| K163359 | ARK Methotrexate Assay | Ark Diagnostics, Inc. | 2017-08-18 | 261 | 0 |
| DEN160033 | ARK Voriconazole II Assay Test System | Ark Diagnostics, Inc. | 2017-05-05 | 294 | 0 |
| K153596 | ARK Oxcarbazepine Metabolite Assay, ARK Oxcarbazepine Metabo | Ark Diagnostics, Inc. | 2016-08-09 | 237 | 0 |
| K111904 | ARK METHOTREXATE ASSAY, ARK METHOTREXATE CALIBRATOR, ARK MET | Ark Diagnostics, Inc. | 2011-10-18 | 105 | 0 |
| K101574 | ARK GABAPENTIN ASSAY, ARK GABEPENTIN CALIFRATOR, AND ARK GAB | Ark Diagnostics, Inc. | 2010-11-23 | 169 | 0 |
| K101305 | ARK LAMOTRIGINE ASSAY, CALIBRATOR & CONTROL | Ark Diagnostics, Inc. | 2010-10-29 | 172 | 0 |
| K091884 | ARK ZONISAMIDE ASSAY, ARK ZONISAMIDE CALIBRATOR, AND ARK ZON | Ark Diagnostics, Inc. | 2009-12-09 | 168 | 0 |
| K091653 | ARK LEVETIRACETAM ASSAY, ARK LEVETIRACETAM CALIBRATOR AND AR | Ark Diagnostics, Inc. | 2009-11-02 | 146 | 0 |
| K083799 | TOPIRAMATE ASSAY, ARK TOPIRAMATE CALIBRATOR AND ARK TOPIRAMA | Ark Diagnostics, Inc. | 2009-04-16 | 115 | 0 |
Methodology
Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.
Prepared with Atlas
Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda